Accessibility navigation


Antisense antiviral compound and method for treating arenavirus infection

AVI Biopharma, The Scripps Research Institute (2009) Antisense antiviral compound and method for treating arenavirus infection. US7582615 B2.

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Official URL: http://www.google.com/patents/US7582615

Abstract/Summary

The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Arenaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Arenavirus infection in a mammal. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5′-terminal regions of the viral RNA, viral complementary RNA and/or mRNA identified by SEQ ID NO:1.

Item Type:Patent
Divisions:Faculty of Life Sciences > School of Biological Sciences > Biomedical Sciences
ID Code:37089
Additional Information:US Patent 7,582,615
Publisher:Google Patents

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation